References
- Choo Q L, Kuo G, Weiner A J, Overby L R, Bradley D W, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–362
- Kuo G, Choo Q L, Alter H J, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–364
- van der Poel C L, Reesink H W, Lelie P N, et al. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet 1989; 2: 297–298
- Esteban J I, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294–297
- Bruix J, Barrera J M, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2: 1004–1006
- Colombo M, Kuo G, Choo Q L, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 1006–1008
- Brillanti S, Barbara L, Miglioli M, Bonino F. Hepatitis C virus: a possible cause of chronic hepatitis in alcoholics. Lancet 1989; 2: 1390–1391
- Sansonno D, Domacco F. Antibodies to hepatitis C virus in non-A, non-B post-transfusion and cryp-togenic chronic liver disease. Lancet 1989; 2: 798–799
- Jeffers L, de Medina M, Hasan F, et al. Hepatitis C (HCV) associated idiopathic chronic hepatitis and cryptogenetic cirrhosis. Hepatology 1989; 10: 644
- Alberti A, Tremolada F, Bortolotti F, et al. Anti-HCV and liver disease in Italy in the last 10 years. Hepatology 1989; 10: 644
- Parker T, de Medina M, Jeffers L, et al. Hepatitis C virus (HCV): a causative agent of cryptogenic cirrhosis (CC) among Cubans. Hepatology 1989; 10: 685
- Katkov W N, Cody H, Evans A A, et al. The role of hepatitis C virus (HCV) in chronic liver disease. Hepatology 1989; 10: 644
- Scheuer P J. Liver biopsy interpretation. Baillière Tindall, London 1984
- Ayola E A, Vennes J A, Siivis S E, Rohrmann C A, Ansel H J. Endoscopic retrograde intrahepatic cho-langiography in liver diseases. Gastrointest Endosc 1976; 22: 156–159
- Mortimer P P, Cohen B J, Litton P A, et al. Hepatitis C virus antibody. Lancet 1989; 2: 798
- McFarlane I G, Smith H M, Johnson P J, Bray G P, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis, pathogenetic factor or false-positive result. Lancet 1990; 1: 754–757
- Zuckerman A J. The elusive hepatitis C virus (Editorial). Br Med J 1989; 299: 871–872